Filing Flows

Filing Flows › Companies › Medinotec › Cash flow

Medinotec cash flow, quarter by quarter

Latest: Q2 FY27 · from the cash-flow statements filed with the SEC

Free cash flow$61K in Q2 FY27 · $374K over twelve months

Operating cash flow$108K
Capital spending−$47K
Free cash flow+$61K
Cash / net income2.6×
Cash conversion cycle20 days

Analysis

In Q2 FY27, Medinotec generated $108K of operating cash flow and spent $47K on capital projects, leaving free cash flow of $61K. That is $1.2M less than in Q2 FY26 ($1.2M).

Over the twelve months to Aug 31, 2026, operating cash flow was $374K; the cash balance rose by $336K.

Operating cash flow was $108K against net income of $41K — 2.6× profit, cash ran ahead of reported earnings. The largest differences: inventory −$288K, payables −$201K, receivables +$189K.

Its cash conversion cycle was 20 days (receivables 74 + inventory 0 − payables 54).

Free cash flow

Medinotec: free cash flow by quarterMedinotec: free cash flow by quarter$52KQ3 FY25$100KQ4 FY25−$759KQ1 FY26$1.2MQ2 FY26$563KQ3 FY26−$121KQ4 FY26−$216KQ1 FY27$61KQ2 FY27
Operating cash flow less capital spending.
Medinotec: operating cash flow against capital spendingMedinotec: operating cash flow against capital spendingOperating cash flowCapital spending$125K$73KQ3 FY25$99K−$1KQ4 FY25−$759K$0Q1 FY26$1.2M$0Q2 FY26$563K$0Q3 FY26−$121K$0Q4 FY26−$176K$40KQ1 FY27$108K$47KQ2 FY27
Latest (Q2 FY27): Operating cash flow $108K, Capital spending $47K.

Capital allocation, year by year

Medinotec: where the cash came from (up) and went (down), by fiscal yearMedinotec: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY23: Operating cash flow −$491KFY23: Net borrowing $279KFY23: Shares issued $3.3MFY23: Capital spending −$55K$3.6MFY23FY24: Operating cash flow $14KFY24: Net borrowing $10KFY24: Capital spending $2K$26KFY24FY25: Operating cash flow $878KFY25: Net borrowing −$895KFY25: Capital spending −$89K$878KFY25FY26: Operating cash flow $907KFY26: Net borrowing −$983KFY26: Capital spending −$1K$907KFY26
Over these 4 years operating cash flow totalled $1.3M; the largest uses were net borrowing ($1.9M) and operating cash flow ($491K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$2.6M
Debtnone
Net cash$2.6M

Medinotec funds itself: free cash flow was $374K over the last twelve months, with $2.6M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Medinotec: sources (+) and uses (−) of cash, Q2 FY27Medinotec: sources (+) and uses (−) of cash, Q2 FY27Operating cash flow$108KCash drawn (+) / kept (−)−$66KCapital spending−$47KExchange rates$5K
Medinotec: sources (+) and uses (−) of cash, TTM to Q2 FY27Medinotec: sources (+) and uses (−) of cash, TTM to Q2 FY27Operating cash flow$374KCash drawn (+) / kept (−)−$336KNot reconciled−$91KExchange rates$53K

From profit to cash

Medinotec: net income to operating cash flow, Q2 FY27Medinotec: net income to operating cash flow, Q2 FY27Net income$41KDepreciation & amortization$22KDeferred taxes−$11KReceivables$189KInventory−$288KPayables−$201KOperating cash flow$108K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 FY2774—5420
Q1 FY2784—7114
Q4 FY26114—10112
Q3 FY2687—96-9
Q2 FY2692—920
Q1 FY26140—8951
Q4 FY2546—84-38
Q3 FY2531—70-39

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q2 FY27$108K−$47K—−$66K$61K
Q1 FY27−$176K−$40K—$239K−$216K
Q4 FY26−$121K——$100K−$121K
Q3 FY26$563K—−$3K−$609K$563K
Q2 FY26$1.2M—−$943K−$297K$1.2M
Q1 FY26−$759K—−$38K$819K−$759K
Q4 FY25$99K$1K−$52K−$93K$100K
Q3 FY25$125K−$73K−$110K$82K$52K

Medinotec: income statement and cash flow

Medinotec, Q2 FY27: revenue $3.2M (-1% year over year), operating margin 6.3%. The chart follows the revenue to costs, profit and cash.

Medinotec: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.